Jump to content

Draft:Filippo Dall'Armellina

From Wikipedia, the free encyclopedia
  • Comment: Far, far more is needed. Please do not clog the system by trying to submit again. Ldm1954 (talk) 13:37, 7 November 2024 (UTC)
  • Comment: Unsure where notability is supposed to lie. What the refs show is that it is in the top 5% of Neuro podcasts - but how do they compare with other podcasts? The sound very niche and, more that one name is listed in the source. The enzyme research does not in itself convey notability. This whole article looks way too soon . This fails WP:GNG and it doesn't help that the refs are poorly formatted , but that isn't a reason for declining the Draft.  Velella  Velella Talk   15:22, 14 October 2024 (UTC)
  • Comment: interviews are not reliable independent sources. Theroadislong (talk) 13:34, 14 October 2024 (UTC)

Filippo Dall'Armellina is an Italian researcher working in the field of protein-lipid biology.

Education and research

[edit]

He appeared on Il Gazzettino newspaper after giving the valedictorian address upon receiving his Bachelor's degree from the University of Liverpool in July 2022.[1][2][3][4].

He is the first author of "In silico modeling human VPS13 proteins associated with donor and target membranes suggests lipid transfer mechanisms," a peer-reviewed study published in the journal Proteins[5]. Funded by the Wellcome Trust, he modeled four human homologs (VPS13A, VPS13B, VPS13C, VPS13D) to explore their lipid transfer abilities. This research proposed a mechanism for lipid transport across organelles via a novel domain that shares structural similarities across different protein families, leading multiple subsequent studies[6][7][8][9][10] to investigate the enigmatic functions of VPS13 proteins in humans and their role in lipid transport across organelles, along with the clinical implications of these mechanisms.

Podcast

[edit]

He hosts Neuro Podcases [11] a podcast on Apple Podcasts and Spotify discussing advancements in neuroscience research and patient care. The podcast was initially developed by John Williamson as an educational tool during the COVID-19 pandemic[12], and since then has gained recognition as one of the top 5% most popular podcasts globally by Listen Notes[13], particularly aimed at neurologists[14]

References

[edit]
  1. ^ "Valedictorian Address". 30 July 2022.
  2. ^ "Research campaign". YouTube. 17 November 2023.
  3. ^ "Liverpool Graduations: Filippo Dall'Armellina".
  4. ^ "Philharmonic Hall Ceremony". YouTube. 18 July 2022.
  5. ^ Dall'Armellina, Filippo (2023). "In silico modeling human VPS13 proteins associated with donor and target membranes suggests lipid transfer mechanisms". Proteins. 91 (4): 439–455. doi:10.1002/prot.26446. PMC 10953354. PMID 36404287.
  6. ^ "J Cell Biol, experimental approach". J Cell Biol.
  7. ^ "J Cell Biol, in silico approach". J Cell Biol.
  8. ^ Dong, Yue; Jia, Milan; Tan, Shuang; Li, Xu-Ying; Song, Yang; Wang, Xianling; Wang, Zhanjun; Wang, Chaodong (26 July 2024). "American J of Medical Genetics". AJ Medical Genetics: e63828. doi:10.1002/ajmg.a.63828. PMID 39058251.
  9. ^ Levine, Tim P. (January 2022). "Sage Journals sequencing study". Sage Journals. 5. doi:10.1177/25152564221134328. PMC 7613979. PMID 36571082.
  10. ^ Walker, Ruth H.; Peikert, Kevin; Jung, Hans H.; Hermann, Andreas; Danek, Adrian (January 2023). "Sage Journals Clinical". Sage Journals. 6. doi:10.1177/25152564231210339. PMC 10714877. PMID 38090146.
  11. ^ "Neuro Podcases".
  12. ^ Bharambe, V., Healy, S., Mayer, J., Williamson, J. (2024). "NeuroPodcases: a clinical neuroscience podcast". Journal of Clinical Neuroscience. xx (xx): xx–xx.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ^ "Ranking". 6 September 2024.
  14. ^ "Podcasts for neurologists".